top of page

Seoul Biomedical International Conference 2019

About Seoul Biomedical International Conference

Seoul Biomedical International Conference 2019 marked its success, following the 2016, 2017, 2018 conferences. Here is the breakdown on Seoul Biomedical International Conference 2019 held on November 4, 2019 at the Seoul City Hall. In the Session 3 of the event, Joseph (Joe) P. McMenamin, an Executive Vice President and Chief Legal Officer with W Medical Strategy Group, delivered a speech crucial to the industry.

Conference’s Objective

  • Presenting global strategies and case studies from the early stage to exit for biomedical startups

  • Providing a platform for a global network and attracting investment

  • Providing opportunities for open innovation cooperation by inviting global leaders of bio-innovation

November 4, 2019

10:00 AM – 16:45 PM (GMT +9)

Conference Hall (8F), Seoul City Hall


10:00-10:15 AM Opening Ceremony

10:15-11:15 AM Keynote Speech

Cost-Effective Drug Discovery and Development

Brian Seed, Professor, Harvard Medical School & Massachusetts General Hospital

  • Successful Technology Commercialization at Marshall University- It's a Team Sport

John Maher, Vice President for Research, Marshall University

  • The Role of the Regulatory Agency in Promoting Innovation in Drug Development

Zili Li, AP R&D Head of Janssen, Johnson & Johnson

11:15-12:15 PM Session 1. Lab to Startup Building

Seoung-Yong Seong (Moderator), Professor, Seoul National University College of Medicine

  • Collaboration of Lab to Start-Up: KRICT Case

Hyuk Lee, Director of Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology

  • Building a Successful Korean/U.S. Hybrid Biotech Startup

Seulki Lee, Professor, Johns Hopkins School of Medicine

  • Discussion

12:15-13:40 PM Networking Luncheon

2:15-3:15 PM Session 2. Incubating & Accelerating

Andy Jang (Moderator), CEO, Starssets Investment

  • Turning Innovations in Genomics into Successful Business – a VC Perspective

Wouter Meuleman, Principal, illumine Ventures

  • Accelerating Innovation through Innovative Partnerships with Leading Academic Institutions and Strategic Partners

Carl S. Goldfischer, President, Forge Bioscience

  • Catalyzing Innovation to Deliver Transformational Solutions

Sharon Chan, Head JLABS @Shanghai, Johnson & Johnson

  • Discussion

3:00-3:20 PM Coffee Break

3:20-4:40 PM Session 3. Business Development

Hyunsang Muk (Moderator), President & CEO, Korea Drug Development Fund

  • Reward is a Function of Risk: Entering the American Market

Joseph McMenamin, EVP and GC, W Medical Strategy Group

  • Key Lessons on How to Negotiate a Successful Deal

Fintan Walton, Founder and CEO, Pharma Ventures

  • Open Innovation Strategy to Build Global Opportunity

Sang Hoon Lee, CEO, ABL BIO

  • Discussion

4:40-4:45 PM Closing


bottom of page